Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer

Bone Marrow Transplant. 2006 Oct;38(8):575-6. doi: 10.1038/sj.bmt.1705483. Epub 2006 Aug 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adolescent
  • Anti-Infective Agents / therapeutic use
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Neoplasms / complications*
  • Protein C / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Sepsis / drug therapy*
  • Sepsis / etiology

Substances

  • Anti-Infective Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated